![](/img/cover-not-exists.png)
BL1 COST-EFFECTIVENESS, VALUE OF INFORMATION, AND BUDGET IMPACT OF CERTOLIZUMAB PEGOL COMPARED TO SUBCUTANEOUS TUMOR NECROSIS FACTOR (TNF) INHIBITORS AND METHOTREXATE IN THE TREATMENT OF MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS IN FINLAND
EJ Soini, T Hallinen, M Taiha, V HonkanenVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(11)71862-9
File:
PDF, 70 KB
english, 2010